Fortuitous discovery of ganglionic tuberculosis after conservative treatment of breast cancer: a case report and review of the literature.
Breast cancer
Chemotherapy and tuberculosis
Ganglionic tuberculosis
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
18 06 2019
18 06 2019
Historique:
received:
10
12
2018
accepted:
11
06
2019
entrez:
20
6
2019
pubmed:
20
6
2019
medline:
18
12
2019
Statut:
epublish
Résumé
Ganglionic tuberculosis is the most common extrapulmonary localization in Morocco. It is still a diagnostic and therapeutic problem especially when the infection is concomitant to the management of a cancer. Here, we report the uncommon case of a fortuitous discovery of ganglionic tuberculosis in the anatomopathological analysis of an axillary node dissection after conservative treatment of breast cancer for a 29-year-old patient without medical history. Her file was discussed in a multidisciplinary consultation meeting during which several decisions were made. We decided to start her antituberculosis treatment then after three weeks her adjuvant chemotherapy with radiotherapy and hormone therapy. Furthermore, giver her young age, she had an oncogenetic consultation. Despite difficulties of therapeutic compliance, the patient completed her cancer treatments after two years, she also cured of her tuberculosis. Being in remission, she is still on hormone therapy and consults every 3-months as part of her follow-up. Cancer and tuberculosis presenting simultaneously creates clinical and histopathological difficulties for differential diagnosis and for therapeutic decisions. Anticancer chemotherapy is not an obstacle in anti-tuberculosis treatment but the compliance of patients to receive both at the same time with the associated side effects is one to consider.
Sections du résumé
BACKGROUND
Ganglionic tuberculosis is the most common extrapulmonary localization in Morocco. It is still a diagnostic and therapeutic problem especially when the infection is concomitant to the management of a cancer.
CASE PRESENTATION
Here, we report the uncommon case of a fortuitous discovery of ganglionic tuberculosis in the anatomopathological analysis of an axillary node dissection after conservative treatment of breast cancer for a 29-year-old patient without medical history. Her file was discussed in a multidisciplinary consultation meeting during which several decisions were made. We decided to start her antituberculosis treatment then after three weeks her adjuvant chemotherapy with radiotherapy and hormone therapy. Furthermore, giver her young age, she had an oncogenetic consultation. Despite difficulties of therapeutic compliance, the patient completed her cancer treatments after two years, she also cured of her tuberculosis. Being in remission, she is still on hormone therapy and consults every 3-months as part of her follow-up.
CONCLUSIONS
Cancer and tuberculosis presenting simultaneously creates clinical and histopathological difficulties for differential diagnosis and for therapeutic decisions. Anticancer chemotherapy is not an obstacle in anti-tuberculosis treatment but the compliance of patients to receive both at the same time with the associated side effects is one to consider.
Identifiants
pubmed: 31215419
doi: 10.1186/s12905-019-0780-8
pii: 10.1186/s12905-019-0780-8
pmc: PMC6582589
doi:
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
79Références
Rom J Morphol Embryol. 2016;57(4):1383-1388
pubmed: 28174808
Crit Care Clin. 2001 Jul;17(3):531-70, vii-viii
pubmed: 11525048
Medicine (Baltimore). 2016 Sep;95(38):e4919
pubmed: 27661041
Yale J Biol Med. 1958 Feb;30(4):257-91
pubmed: 13531168
Br J Cancer. 2013 Mar 19;108(5):1195-208
pubmed: 23449362
N Engl J Med. 2002 Oct 17;347(16):1233-41
pubmed: 12393820
Clin Microbiol Infect. 2004 Aug;10(8):749-52
pubmed: 15301678
Cancer Radiother. 2004 Feb;8(1):21-8
pubmed: 15093197
Clin Infect Dis. 2006 Jun 1;42(11):1592-5
pubmed: 16652317
Ann Surg Oncol. 2007 Nov;14(11):3078-89
pubmed: 17574501
Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):3-16
pubmed: 19469617
Lancet Oncol. 2011 Jun;12(6):520-2
pubmed: 21624773
Am Rev Respir Dis. 1967 May;95(5):729-45
pubmed: 4960690